The effect of epidural infusion of Dexmedetomidine and Ropivacaine on erection following reconstructive urethral surgery

Effectiveness comparison of epidural Dexmedetomidine vs Ropivacaine infusion to prevent erection following reconstructive urethral surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190131042569N4

Enrollment

Registered

2020-08-23

Start date

2020-08-10

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erection.

Interventions

Intervention 1: Intervention group 1: At the end of operation, the continuous infusion pump with a total volume of 100 cc containing dexmedetomidine 50 micro grams and sterile water

6 cc per hour is connected to the epidural catheter. Intervention 2: Intervention group 2: At the end of the operation, the continuous infusion pump with a total volume of 100 cc containing Ropivacain

6 cc per hour is connected to the epidural catheter.

Eligibility

Sex/Gender

Male

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients between 20-60 years old candidate for reconstructive urethral surgery

Exclusion criteria

Exclusion criteria: History of cardiac disease ( Syncope, Arrhythmia and bradycardia) History of allergic reaction to drug which is used in the study

Design outcomes

Primary

Measure	Time frame
Erection after the reconstructive urethral surgery. Timepoint: Daily for one week. Method of measurement: Questionnaire (quality and degree of erection).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNima Saeedi

Shahid Beheshti University of Medical Sciences

nimasaeedi7@yahoo.com+98 21 2641 8939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026